Stock UniverseDerived research view · source repositories remain read-only

Gain Therapeutics, Inc. (GANX)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
28.63
Global Rank
2229
Market Cap
100.39M
Latest Close
1.70
RS Composite
-47.84% · G#3271

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-10.99%
3M
-44.26%
6M
-48.80%
1Y
-14.57%
3Y
-63.12%
5Y
-83.95%
10Y
-86.07%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 614.04K · 30-day average: 624.71K · Max drawdown over stored range: -94.08%

Research Snapshot

Relative Strength vs SPX

RS Composite-47.84%
20D RS-9.73%
60D RS-49.11%
120D RS-65.63%
Global RS Rank3271 · 2.50% percentile
Watch+Speculative RS Rank2026 · 3.39% percentile
Group ScopeWatch+Speculative
Primary RS Rank427 · 6.77% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank338 / 701
Primary Percentile51.93
Score Notesmarket-cap support, industry-tailwind, innovation-keyword, microcap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for GANX.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue00.13390.13260.05520
Revenue Growth (YoY)2600%2600%-0.962%-58.399%2600%
Gross Profit-2.2592-7.0303-8.1104-11.3238-10.6505
Operating Income-3.4794-13.8375-17.7873-22.2579-20.3587
Free Cash Flow-3.2611-12.4599-14.8111-18.8812-18.8963-18.4654
Free Cash Flow Per Share-1.216-1.226-1.246-1.451-0.826-0.5600959660202444
EPS (Diluted) GAAP-1.334254-1.366458-1.480282-1.71139-0.892042
EPS Growth
EPS Non-GAAP
Gross Margin100%100%100%
Operating Margin2600%-10332.052%-13410.178%-40336.856%2600%
Profit Margin2600%-10371.697%-13262.016%-40354.331%2600%
Free Cash Flow Margin2600%-9303.418%-11166.384%-34217.526%2600%
Shares Outstanding (Diluted)2.681410.165411.883413.011422.881432.9683
Shares Change (YoY)19.174%279.107%16.9%9.492%75.857%44.083%

SEC Quarterly Fundamentals

No processed quarterly rows for GANX.